Clinical data show that nausea, vomiting, and gastrointestinal upset occur across all GLP-1 classes, but frequency and severity differ by person, formulation, and titration schedule
doi: 10.1126/science.1170803
Similar content being viewed by others Introduction During the past decade, peptide therapeutics have gained considerable attention in pharmaceutical research and development (R&D) 1,2,3,4
Think of it this way: GLP-1 weight loss medication essentially gives your bodys natural appetite control system a significant boost
Retatrutide is an investigational triple receptor agonist that simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from approved agents such as semaglutide or tirzepatide
When using heating devices, avoid prolonged application, never sleep with heating pads, and use caution if you have reduced sensation or neuropathy to prevent burns